Factors signifying gender differences in clinical presentation of sarcoidosis among Estonian population

2014 ◽  
Vol 10 (3) ◽  
pp. 282-290 ◽  
Author(s):  
Hille Lill ◽  
Kai Kliiman ◽  
Alan Altraja
Keyword(s):  
Gender Differences ◽  
Clinical Presentation ◽  
Estonian Population

Abstract 17356: Gender Differences in Clinical Presentation and Outcomes of Patients With Acute Myocardial Infarction and Spontaneous Coronary Artery Dissection: A Nationwide Inpatient Sample Matched Analysis

Circulation ◽  
2018 ◽  
Vol 138 (Suppl_1) ◽  
Author(s):  
Setri Fugar ◽  
Juliet A Yirerong ◽  
Alfred Solomon ◽  
Ahmed A Kolkailah ◽  
Tauseef Akthar ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Heart Failure ◽  
Gender Differences ◽  
Clinical Presentation ◽  
Artery Dissection ◽  
P Value ◽  
Spontaneous Coronary Artery Dissection ◽  
Coronary Artery Dissection ◽  
Men And Women ◽  
Significant Difference

Introduction: Spontaneous Coronary Artery Dissection (SCAD) is reported to occur predominantly in young women. Gender differences in the clinical presentation and outcomes of patients with SCAD have not been studied on a population level. We sought to compare the in-hospital outcomes of men and women presenting with acute myocardial infarction (AMI) and SCAD. Methods: We identified patients from the National Inpatient Sample (NIS) between 2005 and 2015 who presented with primary diagnoses of AMI and SCAD. We identified SCAD with ICD-9 code 414.12. A 1:1 propensity-matched cohort was created to examine the outcomes between men and women. Primary endpoint was in-hospital mortality. Secondary endpoints included in-hospital cardiac and non-cardiac complications. Results: Of the 6617 (32017 weighted national estimates) patients with SCAD over the study period, majority were males 3667 (55.4%). Males were younger than females (60.32 yr vs. 61.59 yr) and presented more often with ST-elevation myocardial infarction (STEMI) (53.0% vs. 45.9% P=<0.001). Propensity matching yielded 2366 males and 2366 females. In the matched group, there was no significant difference in in-hospital mortality between males and females (OR 1.20 95% CI -0.93-1.54). With regards to in-hospital complications, ventricular tachycardia (V-Tach) was significantly less frequent in females as compared to males (8.0% vs. 10.1% OR 0.76 p-value 0.003). There was no significant difference between females and males in the frequency of other complications, including intracranial hemorrhage (0.2% vs 0.2% OR 1.45 p-value 0.50), GI bleed (1.8% vs 1.3% OR 1.35 p-value 0.13), cardiogenic shock (9.8% vs 9.7% OR 1.01 p-value 0.86), acute heart failure (3% vs 2.6% OR 1.18 p-value 0.26), ventricular fibrillation(vfib) (5.6% vs 6.0% OR 0.928 p-value 0.48) or stroke ( 1.5% vs 1.0% OR 1.535 p-value 0.06) Conclusion: In our large population-based analysis, compared to females, males were more likely to present with STEMI as compared to females. With the except of V-Tach, which was higher in males, there were no significant gender differences in hospital outcomes namely inpatient mortality, cardiogenic, Vfib or acute heart failure.

Gender Differences in the Clinical Presentation of Heart Disease

2011 ◽  
Vol 17 (11) ◽  
pp. 1056-1058 ◽  
Author(s):  
Peter Collins ◽  
Cristiana Vitale ◽  
Ilaria Spoletini ◽  
Giuseppe Barbaro
Keyword(s):  
Gender Differences ◽  
Heart Disease ◽  
Clinical Presentation

Gender Differences in the Presentation and Outcomes of Hospitalized Patients With COVID-19

2021 ◽  
Vol 16 (6) ◽  
Author(s):  
Carloalberto Biolè ◽  
Matteo Bianco ◽  
Iván J Núñez-Gil ◽  
Enrico Cerrato ◽  
Amanda Spirito ◽  
...  
Keyword(s):  
Risk Factors ◽  
Gender Differences ◽  
Renal Failure ◽  
Cardiovascular Risk ◽  
Laboratory Tests ◽  
Clinical Presentation ◽  
C Reactive Protein ◽  
Reactive Protein ◽  
International Registry ◽  
Male Patients

Gender-related differences in COVID-19 clinical presentation, disease progression, and mortality have not been adequately explored. We analyzed the clinical profile, presentation, treatments, and outcomes of patients according to gender in the HOPE-COVID-19 International Registry. Among 2,798 enrolled patients, 1,111 were women (39.7%). Male patients had a higher prevalence of cardiovascular risk factors and more comorbidities at baseline. After propensity score matching, 876 men and 876 women were selected. Male patients more often reported fever, whereas female patients more often reported vomiting, diarrhea, and hyposmia/anosmia. Laboratory tests in men presented alterations consistent with a more severe COVID-19 infection (eg, significantly higher C-reactive protein, troponin, transaminases, lymphocytopenia, thrombocytopenia, and ferritin). Systemic inflammatory response syndrome, bilateral pneumonia, respiratory insufficiency, and renal failure were significantly more frequent in men. Men more often required pronation, corticosteroids, and tocilizumab administration. A significantly higher 30-day mortality was observed in men vs women (23.4% vs 19.2%; P = .039). Trial Numbers: NCT04334291/EUPAS34399.

scholarly journals T127. GENDER DIFFERENCES IN CLINICAL PRESENTATION AND ILLICIT SUBSTANCE USE DURING FIRST EPISODE PSYCHOSIS: AN ELECTRONIC CASE REGISTER NATURAL LANGUAGE PROCESSING ANALYSIS

2020 ◽  
Vol 46 (Supplement_1) ◽  
pp. S278-S279
Author(s):  
Jessica Irving ◽  
Craig Colling ◽  
Hitesh Shetty ◽  
Megan Pritchard ◽  
Robert Stewart ◽  
...  
Keyword(s):  
Gender Differences ◽  
Substance Use ◽  
Language Processing ◽  
Negative Symptoms ◽  
Clinical Presentation ◽  
Psychiatric Symptoms ◽  
First Episode ◽  
Illicit Substance ◽  
Illicit Substance Use ◽  
Male Patients

Abstract Background Gender differences in the clinical presentation of first episode psychosis (FEP) and its relationship to illicit substance use are inconclusive and underexplored. We conducted an electronic health record (EHR) study applying natural language processing (NLP) techniques to investigate gender differences in psychiatric symptoms when controlling for age, ethnicity, and illicit substance use. Methods Data were extracted from EHRs of 3,340 people presenting to the South London and Maudsley (SLaM) NHS Trust between April 2007 and March 2017 with FEP. Logistic regression was used to examine gender differences in presentation of 42 psychiatric symptoms, grouped into positive, negative, depressive, mania and disorganisation symptoms. We controlled for age of onset, ethnicity and illicit substance use (cocaine, amphetamine, MDMA or cannabis) and adjusted p-values for multiple comparisons. Results Patients were predominantly male (62%). Eight symptoms were more prevalent in males (poverty of thought, negative symptoms, social withdrawal, poverty of speech, aggression, grandiosity, paranoia and agitation), and thirteen in females (tearfulness, low energy, reduced appetite, low mood, pressured speech, mood instability, flight of ideas, guilt, mutism, insomnia, poor concentration, tangentiality and elation), before adjustment for age, ethnicity and substance use. Male patients were significantly more likely to experience negative symptoms than females (e.g. poverty of thought, OR 1.85, 95% CI 1.33 to 2.62); female patients showed increased likelihood of depressive and manic symptoms (e.g. tearfulness, 0.30, 0.26 to 0.35). Male patients were significantly more likely to misuse amphetamines, cannabis and cocaine (e.g. cannabis, OR 3.18, 2.75 to 3.70). All significant differences survived controls for age and ethnicity. After adjustment for illicit substance use gender differences in aggression, agitation, paranoia and grandiosity became insignificant (p &gt; 0.05). However, adjustment for illicit substance use resulted in increased strength of gender associations with negative, manic and depression symptoms. Discussion There are clear gender differences in the clinical presentation of FEP which are modified by exposure to illicit substances. These findings highlight a need to better understand the impact of gender on clinical presentation and treatment outcomes in psychosis, and to ensure that clinicians are aware of how gender differences in presentation could be modified by illicit substance use.

Sign in / Sign up

Export Citation Format

Share Document